SCHEMBL7007904

SCHEMBL7007904

Clc1ccc(CC2=NCC(c3ccccc3)CN2)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.44
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
GAA P10253 2/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TAAR1 Q96RJ0 2/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
ADRA2A P08913 1/20 0.35
CYP2D6 P10635 1/20 0.35
TSHR P16473 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
ADRA1D P25100 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
CHRNB2 P17787 1/20 0.34
CHRNB4 P30926 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7007927 0.71 HTR1D (0.57) TAAR1LMNACYP1A2ADRA2ACYP2D6
SCHEMBL7009628 0.70 ALDH1A1 (0.41) GAAMAPTL3MBTL1LMNA
SCHEMBL10506919 0.69 ADRA2B (0.35) ADRA2AADRA2BADRA2C
SCHEMBL7009355 0.69 HTR1D (0.47) TAAR1LMNACYP1A2ADRA2ACYP2D6
SCHEMBL7784836 0.68 L3MBTL1 (0.55) KDM1AMAOAMAOBGAAMAPT
SCHEMBL10505769 0.67 SLC18A3 (0.38) MAOAMAOBGAAMAPTL3MBTL1
SCHEMBL7010617 0.66 LMNA (0.37) GAAMAPTL3MBTL1LMNACHRNB2
Hydrochloric Acid SCHEMBL10684868 0.66 SLC18A3 (0.37) MAOAMAOBL3MBTL1ADRA1DADRA1A
SCHEMBL10187788 0.65 SLC18A3 (0.42) CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7009960 0.64 GAA (0.38) GAAMAPTKDM4EL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030100769-A1 Cyclic amidine compounds DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2003-05-29 US disclosed
EP-1280793-A2 CYCLIC AMIDINE COMPOUNDS AND THEIR USE AS ALPHA4BETA2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS SUNTORY LIMITED (JP) 2003-02-05 EP disclosed
WO-2001081334-A2 CYCLIC AMIDINE COMPOUNDS AND THEIR USE AS ALPHA4BETA2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS SUNTORY LIMITED (JP) 2001-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030100769-A1 Cyclic amidine compounds CHRM1, CHRM5, CCKAR KDM1A 3603/4885MAOA 583/4885MAOB 660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.